Canonical and Non-Canonical Mechanisms of Insulin-Dependent Signaling Regulating Adipogenic Differentiation in Adipose Tissue Renewal.
Bondarev AD., Kulebyakin KY., Gusev NB., Tyurin-Kuzmin PA.
Narrative Review, published in Biochemistry (Mosc) (2026) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Narrative Review
- Journal
- Biochemistry (Mosc) (2026)
- Country
- United States
- Reported sample size
- —
- Source database
- PubMed
- PMID
- 41843884
- DOI
- 10.1134/S0006297925603727
Abstract (original English)
Insulin exerts a complex effect on metabolism, cell growth, and differentiation interacting with its receptor. Adipose tissue is one of the key targets for insulin; in this tissue insulin regulates the processes of energy storage, as well as tissue renewal and emergence of new adipocytes. Insulin activates conversion of glucose into fatty acids, inhibits lipolysis, and induces adipogenic differentiation of adipose tissue stem cells. The insulin receptor is a classic tyrosine kinase receptor that activate phosphoinositide-3-kinase and mitogen-activated protein kinase signaling cascades. At the same time, insulin receptor activates several non-canonical signaling cascades that determine features of the receptor functioning. For example, insulin can affect phosphoinositide metabolism, as well as calcium and redox-dependent signaling. In addition, the insulin receptor can also interact with the trimeric G proteins-coupled receptors (GPCRs). Here, we review canonical and non-canonical signaling cascades activated by the insulin receptor and molecular mechanisms of their involvement in regulating the human adipose tissue renewal.
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.